A Phase 1 trial conducted by QIMR Berghofer researchers in collaboration with UniSC Clinical Trials and sponsored by the not-for-profit Medicines for Malaria Venture (MMV) and GSK, has tested an investigational drug against the malaria parasite in humans for the first time
July 15, 2026
Malaria is a major global health problem affecting more than 280 million people each year and causing an estimated 610,000…